Pre-Tax Profit Margin (Annual)

Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues

IceCure Medical Ltd. (ICCM) had Pre-Tax Profit Margin of -453.76% for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$3.23M
Net Income	$-14.65M
Cost of Goods Sold	$1.93M
Gross Profit	$1.30M
Operating Expenses	$18.80M
Operating Income	$-15.58M
Non-Operating Income/Expense	$0.92M
Pre-Tax Income	$-14.65M
Normalized Pre-Tax Income	$-14.65M
Income after Taxes	$-14.65M
Income from Continuous Operations	$-14.65M
Consolidated Net Income/Loss	$-14.65M
Normalized Income after Taxes	$-14.65M
EBIT	$-15.58M
EBITDA	$-15.25M
Weighted-Average Shares Outstanding (Basic)	45.64M
Weighted-Average Shares Outstanding (Diluted)	45.64M
Earnings per Share (EPS) (Basic)	$-0.32
Earnings per Share (EPS) (Diluted)	$-0.32
Balance Sheet Financials
Current Assets	$14.18M
Property, Plant, and Equipment	$1.51M
Long-Term Assets	$2.23M
Total Assets	$16.41M
Current Liabilities	$3.87M
Long-Term Debt	$0.38M
Long-Term Liabilities	$0.38M
Total Liabilities	$4.25M
Common Equity	$12.16M
Tangible Shareholders Equity	$12.16M
Shareholders Equity	$12.16M
Common Shares Outstanding	45.73M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-12.52M
Cash Flow from Investing Activities	$-0.71M
Cash Flow from Financial Activities	$0.08M
Beginning Cash	$23.66M
End Cash	$10.53M
Increase/Decrease in Cash	$-13.13M
Stock-Based Compensation	$1.31M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.66
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.03
Debt to Equity Ratio	0.05
Gross Margin	40.26%
Operating Margin	-482.38%
EBIT Margin	-482.38%
EBITDA Margin	-472.38%
Pre-Tax Profit Margin	-453.76%
Profit Margin	-453.76%
Free Cash Flow	$-13.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.20
Inventory Turnover	0.85
Receiveable Turnover	31.35
Days Sales in Receivables	11.64
Return on Equity	-120.46%
Return on Tangible Equity	-120.46%
Return on Assets	-89.29%
Return on Investments	-116.85%
Book Value Per Share	$0.27
Free Cash Flow per Share	$-0.28
Operating Cash Flow per Share	$-0.27

Data from Zacks Investment Research, Inc.